With a portfolio spanning specialized skin concerns and a flagship brand dating back to 1890, Spanish cosmetics firm Bella Aurora Labs S.A. has secured $5.4M in new capital. The company, a benchmark in the European cosmetics market, is known for its people-focused business model and expertise in melanocyte behavior, developing patented formulas for hyperpigmentation and hypopigmentation.
Bella Aurora Labs, which employs over 270 people, has a solid presence across Europe, Asia, and the Americas, including subsidiaries in the USA, Mexico, and Brazil. Its recent launch, Repigment12, was recognized with the "Most Innovative Technology" award at the Beauty Innovation Days Awards.















.png&w=3840&q=75)


